カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の人工血液製剤市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Artificial Blood Products Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19162）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19162
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：91
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の人工血液製剤市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

人工血液製剤市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の人工血液製剤の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

人工血液製剤市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・パーフルオロカーボン系酸素運搬体（PFBOC）、ヘモグロビン系酸素運搬体（HBOC）

用途別セグメントは次のように区分されます。
・軍事、民間

世界の人工血液製剤市場の主要な市場プレーヤーは以下のとおりです。
・Aurum Biosciences Ltd.、HEMARINA SA、HbO2 Therapeutics、KaloCyte Inc.、SpheriTech Ltd.、NuvOx Pharma

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、人工血液製剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な人工血液製剤メーカーの企業概要、2019年～2022年までの人工血液製剤の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な人工血液製剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別人工血液製剤の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの人工血液製剤の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での人工血液製剤市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および人工血液製剤の産業チェーンを掲載しています。
・第13、14、15章では、人工血液製剤の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 人工血液製剤の概要
- 種類別分析（2017年vs2021年vs2028年）：パーフルオロカーボン系酸素運搬体（PFBOC）、ヘモグロビン系酸素運搬体（HBOC）
- 用途別分析（2017年vs2021年vs2028年）：軍事、民間
- 世界の人工血液製剤市場規模・予測
- 世界の人工血液製剤生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Aurum Biosciences Ltd.、HEMARINA SA、HbO2 Therapeutics、KaloCyte Inc.、SpheriTech Ltd.、NuvOx Pharma
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：パーフルオロカーボン系酸素運搬体（PFBOC）、ヘモグロビン系酸素運搬体（HBOC）
・用途別分析2017年-2028年：軍事、民間
・人工血液製剤の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・人工血液製剤のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・人工血液製剤のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・人工血液製剤の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・人工血液製剤の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Artificial Blood Products market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Artificial Blood Products market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Military accounting for % of the Artificial Blood Products global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Perfluorocarbon-based Oxygen Carrier (PFBOC) segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Artificial Blood Products include Aurum Biosciences Ltd., HEMARINA SA, HbO2 Therapeutics, KaloCyte Inc., and SpheriTech Ltd., etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Artificial Blood Products market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Perfluorocarbon-based Oxygen Carrier (PFBOC)
Hemoglobin-based Oxygen Carrier (HBOC)
Market segment by Application can be divided into
Military
Civil
The key market players for global Artificial Blood Products market are listed below:
Aurum Biosciences Ltd.
HEMARINA SA
HbO2 Therapeutics
KaloCyte Inc.
SpheriTech Ltd.
NuvOx Pharma
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Artificial Blood Products product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Artificial Blood Products, with price, sales, revenue and global market share of Artificial Blood Products from 2019 to 2022.
Chapter 3, the Artificial Blood Products competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Artificial Blood Products breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Artificial Blood Products market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Artificial Blood Products.
Chapter 13, 14, and 15, to describe Artificial Blood Products sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Artificial Blood Products Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Artificial Blood Products Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Perfluorocarbon-based Oxygen Carrier (PFBOC)
1.2.3 Hemoglobin-based Oxygen Carrier (HBOC)
1.3 Market Analysis by Application
1.3.1 Overview: Global Artificial Blood Products Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Military
1.3.3 Civil
1.4 Global Artificial Blood Products Market Size & Forecast
1.4.1 Global Artificial Blood Products Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Artificial Blood Products Sales in Volume (2017-2028)
1.4.3 Global Artificial Blood Products Price (2017-2028)
1.5 Global Artificial Blood Products Production Capacity Analysis
1.5.1 Global Artificial Blood Products Total Production Capacity (2017-2028)
1.5.2 Global Artificial Blood Products Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Artificial Blood Products Market Drivers
1.6.2 Artificial Blood Products Market Restraints
1.6.3 Artificial Blood Products Trends Analysis
2 Manufacturers Profiles
2.1 Aurum Biosciences Ltd.
2.1.1 Aurum Biosciences Ltd. Details
2.1.2 Aurum Biosciences Ltd. Major Business
2.1.3 Aurum Biosciences Ltd. Artificial Blood Products Product and Services
2.1.4 Aurum Biosciences Ltd. Artificial Blood Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 HEMARINA SA
2.2.1 HEMARINA SA Details
2.2.2 HEMARINA SA Major Business
2.2.3 HEMARINA SA Artificial Blood Products Product and Services
2.2.4 HEMARINA SA Artificial Blood Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 HbO2 Therapeutics
2.3.1 HbO2 Therapeutics Details
2.3.2 HbO2 Therapeutics Major Business
2.3.3 HbO2 Therapeutics Artificial Blood Products Product and Services
2.3.4 HbO2 Therapeutics Artificial Blood Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 KaloCyte Inc.
2.4.1 KaloCyte Inc. Details
2.4.2 KaloCyte Inc. Major Business
2.4.3 KaloCyte Inc. Artificial Blood Products Product and Services
2.4.4 KaloCyte Inc. Artificial Blood Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 SpheriTech Ltd.
2.5.1 SpheriTech Ltd. Details
2.5.2 SpheriTech Ltd. Major Business
2.5.3 SpheriTech Ltd. Artificial Blood Products Product and Services
2.5.4 SpheriTech Ltd. Artificial Blood Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 NuvOx Pharma
2.6.1 NuvOx Pharma Details
2.6.2 NuvOx Pharma Major Business
2.6.3 NuvOx Pharma Artificial Blood Products Product and Services
2.6.4 NuvOx Pharma Artificial Blood Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Artificial Blood Products Breakdown Data by Manufacturer
3.1 Global Artificial Blood Products Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Artificial Blood Products Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Artificial Blood Products
3.4 Market Concentration Rate
3.4.1 Top 3 Artificial Blood Products Manufacturer Market Share in 2021
3.4.2 Top 6 Artificial Blood Products Manufacturer Market Share in 2021
3.5 Global Artificial Blood Products Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Artificial Blood Products Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Artificial Blood Products Market Size by Region
4.1.1 Global Artificial Blood Products Sales in Volume by Region (2017-2028)
4.1.2 Global Artificial Blood Products Revenue by Region (2017-2028)
4.2 North America Artificial Blood Products Revenue (2017-2028)
4.3 Europe Artificial Blood Products Revenue (2017-2028)
4.4 Asia-Pacific Artificial Blood Products Revenue (2017-2028)
4.5 South America Artificial Blood Products Revenue (2017-2028)
4.6 Middle East and Africa Artificial Blood Products Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Artificial Blood Products Sales in Volume by Type (2017-2028)
5.2 Global Artificial Blood Products Revenue by Type (2017-2028)
5.3 Global Artificial Blood Products Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Artificial Blood Products Sales in Volume by Application (2017-2028)
6.2 Global Artificial Blood Products Revenue by Application (2017-2028)
6.3 Global Artificial Blood Products Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Artificial Blood Products Sales by Type (2017-2028)
7.2 North America Artificial Blood Products Sales by Application (2017-2028)
7.3 North America Artificial Blood Products Market Size by Country
7.3.1 North America Artificial Blood Products Sales in Volume by Country (2017-2028)
7.3.2 North America Artificial Blood Products Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Artificial Blood Products Sales by Type (2017-2028)
8.2 Europe Artificial Blood Products Sales by Application (2017-2028)
8.3 Europe Artificial Blood Products Market Size by Country
8.3.1 Europe Artificial Blood Products Sales in Volume by Country (2017-2028)
8.3.2 Europe Artificial Blood Products Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Artificial Blood Products Sales by Type (2017-2028)
9.2 Asia-Pacific Artificial Blood Products Sales by Application (2017-2028)
9.3 Asia-Pacific Artificial Blood Products Market Size by Region
9.3.1 Asia-Pacific Artificial Blood Products Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Artificial Blood Products Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Artificial Blood Products Sales by Type (2017-2028)
10.2 South America Artificial Blood Products Sales by Application (2017-2028)
10.3 South America Artificial Blood Products Market Size by Country
10.3.1 South America Artificial Blood Products Sales in Volume by Country (2017-2028)
10.3.2 South America Artificial Blood Products Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Artificial Blood Products Sales by Type (2017-2028)
11.2 Middle East & Africa Artificial Blood Products Sales by Application (2017-2028)
11.3 Middle East & Africa Artificial Blood Products Market Size by Country
11.3.1 Middle East & Africa Artificial Blood Products Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Artificial Blood Products Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Artificial Blood Products and Key Manufacturers
12.2 Manufacturing Costs Percentage of Artificial Blood Products
12.3 Artificial Blood Products Production Process
12.4 Artificial Blood Products Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Artificial Blood Products Typical Distributors
13.3 Artificial Blood Products Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Artificial Blood Products Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Artificial Blood Products Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Aurum Biosciences Ltd. Basic Information, Manufacturing Base and Competitors
Table 4. Aurum Biosciences Ltd. Major Business
Table 5. Aurum Biosciences Ltd. Artificial Blood Products Product and Services
Table 6. Aurum Biosciences Ltd. Artificial Blood Products Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. HEMARINA SA Basic Information, Manufacturing Base and Competitors
Table 8. HEMARINA SA Major Business
Table 9. HEMARINA SA Artificial Blood Products Product and Services
Table 10. HEMARINA SA Artificial Blood Products Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. HbO2 Therapeutics Basic Information, Manufacturing Base and Competitors
Table 12. HbO2 Therapeutics Major Business
Table 13. HbO2 Therapeutics Artificial Blood Products Product and Services
Table 14. HbO2 Therapeutics Artificial Blood Products Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. KaloCyte Inc. Basic Information, Manufacturing Base and Competitors
Table 16. KaloCyte Inc. Major Business
Table 17. KaloCyte Inc. Artificial Blood Products Product and Services
Table 18. KaloCyte Inc. Artificial Blood Products Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. SpheriTech Ltd. Basic Information, Manufacturing Base and Competitors
Table 20. SpheriTech Ltd. Major Business
Table 21. SpheriTech Ltd. Artificial Blood Products Product and Services
Table 22. SpheriTech Ltd. Artificial Blood Products Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. NuvOx Pharma Basic Information, Manufacturing Base and Competitors
Table 24. NuvOx Pharma Major Business
Table 25. NuvOx Pharma Artificial Blood Products Product and Services
Table 26. NuvOx Pharma Artificial Blood Products Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Global Artificial Blood Products Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 28. Global Artificial Blood Products Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 29. Market Position of Manufacturers in Artificial Blood Products, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 30. Global Artificial Blood Products Production Capacity by Company, (K Units): 2020 VS 2021
Table 31. Head Office and Artificial Blood Products Production Site of Key Manufacturer
Table 32. Artificial Blood Products New Entrant and Capacity Expansion Plans
Table 33. Artificial Blood Products Mergers & Acquisitions in the Past Five Years
Table 34. Global Artificial Blood Products Sales by Region (2017-2022) & (K Units)
Table 35. Global Artificial Blood Products Sales by Region (2023-2028) & (K Units)
Table 36. Global Artificial Blood Products Revenue by Region (2017-2022) & (USD Million)
Table 37. Global Artificial Blood Products Revenue by Region (2023-2028) & (USD Million)
Table 38. Global Artificial Blood Products Sales by Type (2017-2022) & (K Units)
Table 39. Global Artificial Blood Products Sales by Type (2023-2028) & (K Units)
Table 40. Global Artificial Blood Products Revenue by Type (2017-2022) & (USD Million)
Table 41. Global Artificial Blood Products Revenue by Type (2023-2028) & (USD Million)
Table 42. Global Artificial Blood Products Price by Type (2017-2022) & (US$/Unit)
Table 43. Global Artificial Blood Products Price by Type (2023-2028) & (US$/Unit)
Table 44. Global Artificial Blood Products Sales by Application (2017-2022) & (K Units)
Table 45. Global Artificial Blood Products Sales by Application (2023-2028) & (K Units)
Table 46. Global Artificial Blood Products Revenue by Application (2017-2022) & (USD Million)
Table 47. Global Artificial Blood Products Revenue by Application (2023-2028) & (USD Million)
Table 48. Global Artificial Blood Products Price by Application (2017-2022) & (US$/Unit)
Table 49. Global Artificial Blood Products Price by Application (2023-2028) & (US$/Unit)
Table 50. North America Artificial Blood Products Sales by Country (2017-2022) & (K Units)
Table 51. North America Artificial Blood Products Sales by Country (2023-2028) & (K Units)
Table 52. North America Artificial Blood Products Revenue by Country (2017-2022) & (USD Million)
Table 53. North America Artificial Blood Products Revenue by Country (2023-2028) & (USD Million)
Table 54. North America Artificial Blood Products Sales by Type (2017-2022) & (K Units)
Table 55. North America Artificial Blood Products Sales by Type (2023-2028) & (K Units)
Table 56. North America Artificial Blood Products Sales by Application (2017-2022) & (K Units)
Table 57. North America Artificial Blood Products Sales by Application (2023-2028) & (K Units)
Table 58. Europe Artificial Blood Products Sales by Country (2017-2022) & (K Units)
Table 59. Europe Artificial Blood Products Sales by Country (2023-2028) & (K Units)
Table 60. Europe Artificial Blood Products Revenue by Country (2017-2022) & (USD Million)
Table 61. Europe Artificial Blood Products Revenue by Country (2023-2028) & (USD Million)
Table 62. Europe Artificial Blood Products Sales by Type (2017-2022) & (K Units)
Table 63. Europe Artificial Blood Products Sales by Type (2023-2028) & (K Units)
Table 64. Europe Artificial Blood Products Sales by Application (2017-2022) & (K Units)
Table 65. Europe Artificial Blood Products Sales by Application (2023-2028) & (K Units)
Table 66. Asia-Pacific Artificial Blood Products Sales by Region (2017-2022) & (K Units)
Table 67. Asia-Pacific Artificial Blood Products Sales by Region (2023-2028) & (K Units)
Table 68. Asia-Pacific Artificial Blood Products Revenue by Region (2017-2022) & (USD Million)
Table 69. Asia-Pacific Artificial Blood Products Revenue by Region (2023-2028) & (USD Million)
Table 70. Asia-Pacific Artificial Blood Products Sales by Type (2017-2022) & (K Units)
Table 71. Asia-Pacific Artificial Blood Products Sales by Type (2023-2028) & (K Units)
Table 72. Asia-Pacific Artificial Blood Products Sales by Application (2017-2022) & (K Units)
Table 73. Asia-Pacific Artificial Blood Products Sales by Application (2023-2028) & (K Units)
Table 74. South America Artificial Blood Products Sales by Country (2017-2022) & (K Units)
Table 75. South America Artificial Blood Products Sales by Country (2023-2028) & (K Units)
Table 76. South America Artificial Blood Products Revenue by Country (2017-2022) & (USD Million)
Table 77. South America Artificial Blood Products Revenue by Country (2023-2028) & (USD Million)
Table 78. South America Artificial Blood Products Sales by Type (2017-2022) & (K Units)
Table 79. South America Artificial Blood Products Sales by Type (2023-2028) & (K Units)
Table 80. South America Artificial Blood Products Sales by Application (2017-2022) & (K Units)
Table 81. South America Artificial Blood Products Sales by Application (2023-2028) & (K Units)
Table 82. Middle East & Africa Artificial Blood Products Sales by Region (2017-2022) & (K Units)
Table 83. Middle East & Africa Artificial Blood Products Sales by Region (2023-2028) & (K Units)
Table 84. Middle East & Africa Artificial Blood Products Revenue by Region (2017-2022) & (USD Million)
Table 85. Middle East & Africa Artificial Blood Products Revenue by Region (2023-2028) & (USD Million)
Table 86. Middle East & Africa Artificial Blood Products Sales by Type (2017-2022) & (K Units)
Table 87. Middle East & Africa Artificial Blood Products Sales by Type (2023-2028) & (K Units)
Table 88. Middle East & Africa Artificial Blood Products Sales by Application (2017-2022) & (K Units)
Table 89. Middle East & Africa Artificial Blood Products Sales by Application (2023-2028) & (K Units)
Table 90. Artificial Blood Products Raw Material
Table 91. Key Manufacturers of Artificial Blood Products Raw Materials
Table 92. Direct Channel Pros & Cons
Table 93. Indirect Channel Pros & Cons
Table 94. Artificial Blood Products Typical Distributors
Table 95. Artificial Blood Products Typical Customers
List of Figures
Figure 1. Artificial Blood Products Picture
Figure 2. Global Artificial Blood Products Revenue Market Share by Type in 2021
Figure 3. Perfluorocarbon-based Oxygen Carrier (PFBOC)
Figure 4. Hemoglobin-based Oxygen Carrier (HBOC)
Figure 5. Global Artificial Blood Products Revenue Market Share by Application in 2021
Figure 6. Military
Figure 7. Civil
Figure 8. Global Artificial Blood Products Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 9. Global Artificial Blood Products Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Artificial Blood Products Sales (2017-2028) & (K Units)
Figure 11. Global Artificial Blood Products Price (2017-2028) & (US$/Unit)
Figure 12. Global Artificial Blood Products Production Capacity (2017-2028) & (K Units)
Figure 13. Global Artificial Blood Products Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Artificial Blood Products Market Drivers
Figure 15. Artificial Blood Products Market Restraints
Figure 16. Artificial Blood Products Market Trends
Figure 17. Global Artificial Blood Products Sales Market Share by Manufacturer in 2021
Figure 18. Global Artificial Blood Products Revenue Market Share by Manufacturer in 2021
Figure 19. Artificial Blood Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Artificial Blood Products Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Artificial Blood Products Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Artificial Blood Products Sales Market Share by Region (2017-2028)
Figure 23. Global Artificial Blood Products Revenue Market Share by Region (2017-2028)
Figure 24. North America Artificial Blood Products Revenue (2017-2028) & (USD Million)
Figure 25. Europe Artificial Blood Products Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Artificial Blood Products Revenue (2017-2028) & (USD Million)
Figure 27. South America Artificial Blood Products Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Artificial Blood Products Revenue (2017-2028) & (USD Million)
Figure 29. Global Artificial Blood Products Sales Market Share by Type (2017-2028)
Figure 30. Global Artificial Blood Products Revenue Market Share by Type (2017-2028)
Figure 31. Global Artificial Blood Products Price by Type (2017-2028) & (US$/Unit)
Figure 32. Global Artificial Blood Products Sales Market Share by Application (2017-2028)
Figure 33. Global Artificial Blood Products Revenue Market Share by Application (2017-2028)
Figure 34. Global Artificial Blood Products Price by Application (2017-2028) & (US$/Unit)
Figure 35. North America Artificial Blood Products Sales Market Share by Type (2017-2028)
Figure 36. North America Artificial Blood Products Sales Market Share by Application (2017-2028)
Figure 37. North America Artificial Blood Products Sales Market Share by Country (2017-2028)
Figure 38. North America Artificial Blood Products Revenue Market Share by Country (2017-2028)
Figure 39. United States Artificial Blood Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Artificial Blood Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Artificial Blood Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Artificial Blood Products Sales Market Share by Type (2017-2028)
Figure 43. Europe Artificial Blood Products Sales Market Share by Application (2017-2028)
Figure 44. Europe Artificial Blood Products Sales Market Share by Country (2017-2028)
Figure 45. Europe Artificial Blood Products Revenue Market Share by Country (2017-2028)
Figure 46. Germany Artificial Blood Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Artificial Blood Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Artificial Blood Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Artificial Blood Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Artificial Blood Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Artificial Blood Products Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Artificial Blood Products Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Artificial Blood Products Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Artificial Blood Products Revenue Market Share by Region (2017-2028)
Figure 55. China Artificial Blood Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Artificial Blood Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Artificial Blood Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Artificial Blood Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Artificial Blood Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Artificial Blood Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Artificial Blood Products Sales Market Share by Type (2017-2028)
Figure 62. South America Artificial Blood Products Sales Market Share by Application (2017-2028)
Figure 63. South America Artificial Blood Products Sales Market Share by Country (2017-2028)
Figure 64. South America Artificial Blood Products Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Artificial Blood Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Artificial Blood Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Artificial Blood Products Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Artificial Blood Products Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Artificial Blood Products Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Artificial Blood Products Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Artificial Blood Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Artificial Blood Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Artificial Blood Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Artificial Blood Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Artificial Blood Products in 2021
Figure 76. Manufacturing Process Analysis of Artificial Blood Products
Figure 77. Artificial Blood Products Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の人工血液ポンプ市場2022年：市場規模予測（～2028年）
  • 人工血管の世界市場 2022年-2026年
  • 大&中径人工血管のグローバル市場展望 2023年-2029年：（mm）、6-10、10以上
  • 世界の血液生物学的製剤市場2022年：市場規模予測（～2028年）
  • 世界の人工大理石製品市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19162 )"世界の人工血液製剤市場2022年：市場規模予測（～2028年）" (英文：Global Artificial Blood Products Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。